Survey: Consumers Hold Drug Companies Responsible for High Prices and Out-of-Pocket Costs
November 30, 2016
A new national survey finds most voters blame drug companies not only for high drug prices, also for out-of-pocket costs...
Survey: Consumers Hold Drug Companies Responsible for High Prices and Out-of-Pocket Costs
November 30, 2016
A new national survey finds most voters blame drug companies not only for high drug prices, also for out-of-pocket costs...
The Return on Investment (ROI) on PBM Services
November 21, 2016
An analysis from Visante quantifying how PBMs generate $6 in savings for each $1 spent on their services. Major Findings...
Medicaid Pharmacy Savings Opportunities: National and State-Specific Estimates
October 13, 2016
Executive Summary This study examines whether the full range of pharmacy benefit management (PBM) tools are being allowed and used...
Report: Comparison of Hepatitis C Treatment Costs
September 23, 2016
A report from IMS Institute for Healthcare Informatics shows Hepatitis C drug prices, specifically negotiated by pharmacy benefit managers (PBMs)...
September 21, 2016
EpiPen prices far outpace cost sharing: Mylan has increased their list price from $100 in 2009 to over $600 in...
North Star Survey of Business Owners and Executives
September 13, 2016
This survey of 400 small business owners and medium-to-large business executives, conducted online July 26-29, 2016, shows that business leaders...